Eli Lilly & Co. (NYSE:LLY)

Eli Lilly Logo

Eli Lilly Continues to Rise on Positive Jardiance Results

Eli Lilly and Co. (NYSE: LLY) shares got a solid boost in the market Thursday morning as the broad markets were selling off. In fact this major pharmaceutical company has ...
Read Full Story »
coffee cup

Merrill Lynch US 1 List Update: Momentum Stock Panera Bread Is Out

Uh oh, it seems as though some of the portfolio strategists are maybe starting to get a little nervous as the summer winds down and the danger months of September ...
Read Full Story »
Prescription drugs

4 Top Pharma Stocks That Should Outperform Out To 2016

With a very nervous market, and the end of summer doldrums upon us, it may be time to look for ideas that will make sense when the market heats back ...
Read Full Story »
Pfizer logo

4 Large Cap Pharmaceutical Stocks to Buy on Strong Health Care Trends

One of the metrics that analysts and strategists follow closely is the three-month earnings revision ratio. While analysts continue to make more downward to upward revisions, the number is improving. ...
Read Full Story »
Eli Lilly Logo

How Much New Eli Lilly Product Launches Boosted the Bottom Line

Eli Lilly and Co. (NYSE: LLY) reported its second-quarter earnings Thursday before the markets opened. The company had $0.90 in earnings per share (EPS) on $4.98 billion in revenue. That ...
Read Full Story »
biotech

Top Health Care Earnings for the Week Ahead

Earnings season is hitting its stride next week, and we have taken a look at companies in a variety of sectors that will be posting results next week. The health ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Eli Lilly, Hertz, LinkedIn, NetApp, SINA, Vodafone, Wells Fargo and More

Stocks were indicated marginally higher on Wednesday ahead of another vote in Greece. The trend that is now almost four years old is that investors just keep buying every dip ...
Read Full Story »
Eli Lilly Logo

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

While it appears at least for the time being that the Greek can once again has been kicked down the road, looking for solid more defensive stocks still makes good ...
Read Full Story »
fda_logo

5 Big Upcoming FDA Decisions Expected in July

Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, similar to that ...
Read Full Story »
Eli Lilly Logo

4 Merrill Lynch Catalyst-Driven Stock Ideas to Buy Now

With second-quarter earnings right around the corner, many investors are trying to size up what stocks have the potential to trade meaningfully higher the rest of the year. A new ...
Read Full Story »
Pills

Is Big Pharma Advertising Getting Out of Control?

How much are big pharmaceutical companies really spending to get their drugs out there in the public eye? In 2014, these companies spent about $4.5 billion in advertising alone, notably ...
Read Full Story »
Prescription drugs

Are Cancer Drugs Becoming Too Costly for Their Effectiveness?

When the American Society of Clinical Oncology (ASCO) decided to create a rating scale for cancer drugs, it certainly must have expected to get some pushback. The group’s initial version ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Amazon, CenturyLink, Fitbit, Mobileye, Eli Lilly, Netflix, AT&T and More

Stocks were indicated higher on Thursday. With markets close to all-time highs, the one trend seen for nearly four years now is that investors have bought every single stock market ...
Read Full Story »
buy sell

4 Top New Growth Stock Picks From Jefferies

As we get closer to second quarter earnings, many investors on Wall Street and Main Street are starting to concentrate on having stocks in portfolios that can not only hit ...
Read Full Story »
Eli Lilly Logo

Key Analyst Sees Solid Upside in Eli Lilly

Eli Lilly & Co. (NYSE: LLY) has made a big splash in the market over the past year. A key analyst sees this trend continuing despite some potential near-term headwinds. ...
Read Full Story »